Position: Chief Business Development Officer (since 1 January 2023) 

Number of shares in Navamedic ASA:  575,000 

Year of birth:  1959 

Current external directorships: Nomvec AS 

Experience: 

From 2019 through 2022 Eriksen held the position as Chief Operating Officer, which included Supply Chain and Business Development at Navamedic. Before joining Navamedic, Eriksen served as Chief Operating Officer and Head of Business Development at Weifa ASA from 2014 to 2018. Prior to that, Eriksen has extensive experience from the pharma industry, including R&D at Nycomed Imaging AS and executive positions at Clavis Pharma ASA, NeoRad AS and Alertis Medical AS. Eriksen has served as board member of several companies, including Charman of Genetic Analysis AS. 

Education: 

Eriksen holds a master’s degree (MSc) in Organic Chemistry from the Norwegian University of Science and Technology in Trondheim.